Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,570 studies match

clinicaltrialsPublishedShowing 101–150 of 2,570 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07206056	An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)(TulmiSTAR-01)	recruiting	Phase 1 / Phase 2	188	Novartis PharmaceuticalsINDUSTRY	14	Sep 18, 2026	clinicaltrials
NCT02436707	Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma	active not recruiting	Phase 2	129	Canadian Cancer Trials Group